hydrochlorothiazide has been researched along with Arrhythmogenic Right Ventricular Cardiomyopathy in 1 studies
Hydrochlorothiazide: A thiazide diuretic often considered the prototypical member of this class. It reduces the reabsorption of electrolytes from the renal tubules. This results in increased excretion of water and electrolytes, including sodium, potassium, chloride, and magnesium. It is used in the treatment of several disorders including edema, hypertension, diabetes insipidus, and hypoparathyroidism.
hydrochlorothiazide : A benzothiadiazine that is 3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide substituted by a chloro group at position 6 and a sulfonamide at 7. It is diuretic used for the treatment of hypertension and congestive heart failure.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kalantarian, S | 1 |
| Vittinghoff, E | 1 |
| Klein, L | 1 |
| Scheinman, MM | 1 |
1 other study available for hydrochlorothiazide and Arrhythmogenic Right Ventricular Cardiomyopathy
| Article | Year |
|---|---|
Effect of preload reducing therapy on right ventricular size and function in patients with arrhythmogenic right ventricular cardiomyopathy.
Topics: Adult; Arrhythmogenic Right Ventricular Dysplasia; Dose-Response Relationship, Drug; Drug Combinatio | 2021 |